These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6217250)

  • 1. Cellular interactions in marrow-grafted patients. I. Impairment of cell-mediated lympholysis associated with graft-vs-host disease and the effect of interleukin 2.
    Mori T; Tsoi MS; Gillis S; Santos E; Thomas ED; Storb R
    J Immunol; 1983 Feb; 130(2):712-6. PubMed ID: 6217250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular interactions in marrow-grafted patients. III. Normal interleukin 1 and defective interleukin 2 production in short-term patients and in those with chronic graft-versus-host disease.
    Brkic S; Tsoi MS; Mori T; Lachman L; Gillis S; Thomas ED; Storb R
    Transplantation; 1985 Jan; 39(1):30-5. PubMed ID: 3880962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS; Storb R; Weiden PL; Thomas ED
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity to non-HLA antigens of the host by donor lymphocytes in patients with chronic graft-vs-host disease.
    Tsoi MS; Storb R; Dobbs S; Medill L; Thomas ED
    J Immunol; 1980 Nov; 125(5):2258-62. PubMed ID: 6448894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonspecific suppressor cells in patients with chronic graft-vs-host disease after marrow grafting.
    Tsoi MS; Storb R; Dobbs S; Kopecky KJ; Santos E; Weiden PL; Thomas ED
    J Immunol; 1979 Nov; 123(5):1970-6. PubMed ID: 39962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of prostaglandin E2 restores defective lymphocyte proliferation and cell-mediated lympholysis in recipients after allogeneic marrow grafting.
    Klingemann HG; Tsoi MS; Storb R
    Blood; 1986 Jul; 68(1):102-7. PubMed ID: 2941083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease.
    Tsoi MS; Dobbs S; Brkic S; Ramberg R; Thomas ED; Storb R
    Transplantation; 1984 Jun; 37(6):556-61. PubMed ID: 6233768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients: implications for the mechanisms of graft-host tolerance and chronic graft-versus-host disease.
    Tsoi MS; Storb R; Dobbs S; Santos E; Thomas ED
    Transplant Proc; 1981 Mar; 13(1 Pt 1):237-40. PubMed ID: 6455791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ineffective cellular interaction and interleukin 2 deficiency causing T cell defects in human allogeneic marrow recipients early after grafting and in those with chronic graft-versus-host disease.
    Tsoi MS; Mori T; Brkic S; Dobbs S; Gillis S; Santos E; Thomas ED; Storb R
    Transplant Proc; 1984 Dec; 16(6):1470-2. PubMed ID: 6390848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous mixed lymphocyte reaction in man. XII. Deficiency of the autologous mixed lymphocyte reaction in patients undergoing allogeneic bone marrow transplantation. Relationship with chronic graft-versus-host disease.
    Gupta S; Kapoor N; O'Reilly R; Good RA
    J Clin Lab Immunol; 1984 Aug; 14(4):173-5. PubMed ID: 6238167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and concanavalin A induced suppressor cell activity in patients undergoing bone marrow transplantation: relationship with acute and chronic graft versus host disease.
    Gupta S; Kapoor N; O'Reilly R; Good R
    J Clin Lab Immunol; 1983 Mar; 10(3):121-5. PubMed ID: 6221107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of host-specific interleukin 2-secreting T helper cell precursors correlates closely with active primary and secondary chronic graft-versus-host disease.
    Bunjes D; Theobald M; Nierle T; Arnold R; Heimpel H
    Bone Marrow Transplant; 1995 May; 15(5):727-32. PubMed ID: 7670402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of CD8 cytolytic T cells early after autologous or allogeneic bone marrow transplantation.
    Charmot D; Ragueneau M; Olive D; Maraninchi D; Mawas C
    Bone Marrow Transplant; 1987 Aug; 2(2):183-94. PubMed ID: 2901879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Theobald M; Nierle T; Bunjes D; Arnold R; Heimpel H
    N Engl J Med; 1992 Dec; 327(23):1613-7. PubMed ID: 1435898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.